Patent & Trade Mark
Attorneys
Steve Gledhill
Steve Gledhill
Partner


Level 23, 44 Market Street
Sydney NSW 2000
AUSTRALIA
Tel +61 2 8231 1048
Fax +61 2 8231 1099
Recent Publications
11 May 2018
On 26 April 2018 the UK government ratified the agreement aimed at establishing the long-awaited Unified Patent Court (UPC) in Europe. The fate of the UPC now rests with Germany as the only remaining country still required to ratify the agreement before it can come into effect. There remains some uncertainty around exactly when that will happen. Nevertheless, the UK’s ratification represents a significant step towards implementation of a radically different framework for patent enforcement in Europe. We recommend that Australian and New Zealand companies take note in preparation for the changes ahead.

27 Jun 2016
On 23 June the UK voted to leave the European Union, creating widespread uncertainty over the economic futures of both the UK and the EU. Here we answer the immediate questions about what impact the “Brexit” has on your IP rights.

Steve is a Partner with the Biotechnology team in Sydney.

As well as being a registered Australian and New Zealand Patent Attorney, Steve has qualified as a UK and European Patent Attorney and has considerable International experience, having worked at a top tier London firm of European Patent attorneys for a significant period of time.

Steve provides an extensive range of intellectual property services for clients, ranging from contentious matters including patent oppositions and litigation support in Australia and internationally; to advising on due diligence, infringement and freedom to operate matters; and devising patent prosecution strategies from drafting through to global patent portfolio management. Of particular note is Steve’s involvement in contentious proceedings before the Australian Patent Office, the Intellectual Property Office of New Zealand, the Federal Court of Australia and the European Patent Office, in which he has achieved notable successes.

A defining feature of Steve’s practice is his particularly personable nature. Steve contends that by taking the time to get to know how clients prefer to work, a stronger, more constructive outcome is invariably achieved. He has a range of clients including large multinational corporations, universities, spin-offs, research institutes, SMEs and individual inventors, and adapts his practice to the particular needs of each.

Steve also has significant “in-house” experience, having been seconded to a leading Australian medical research institute for a period of time since 2011. Steve actively manages this institute’s patent portfolio and advises on the patentability of new research, regularly working on site together with the commercialisation team to ensure that his advice is attuned to this client’s commercial goals.

Steve regularly presents on case law and general intellectual property issues and is known for his ability to express complex science and technology clearly to audiences at a wide range of knowledge levels. A Senior Fellow of University of Melbourne Law School, Steve also actively contributes to the training of junior attorneys.

Steve is a registered Australian and New Zealand Patent Attorney.

Education
  • 1st class BA (Hons) degree in Biological Sciences from Oxford University (Balliol College)
  • Certificate of Intellectual Property Law from Queen Mary College, University of  London
  • Qualifying examinations at the Australian, UK and European Patent Offices
  • DibbsBarker Award for 'the best performance in Patent Law' University of Technology, Sydney
Key Areas of Expertise
  • Therapeutics
  • siRNA/antisense
  • Transgenics
  • Immunology
  • Microfluidics
Industry Focus

Professional Affiliations

  • Member of the Institute of Patent and Trade Mark Attorneys of Australia
  • Member of the Australian Institute of Company Directors
  • Member of the Chartered Institute of Patent Attorneys